Research ArticleOriginal Research

Physiologic Effects of High-Flow Nasal Cannula in Healthy Subjects

Mathieu Delorme, Pierre-Alexandre Bouchard, Mathieu Simon, Serge Simard and François Lellouche
Respiratory Care September 2020, 65 (9) 1346-1354; DOI: https://doi.org/10.4187/respcare.07306

References

  1. 1.↵
    1. Maggiore SM,
    2. Idone FA,
    3. Vaschetto R,
    4. Festa R,
    5. Cataldo A,
    6. Antonicelli F,
    7. et al
    . Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med 2014;190(3):282–288.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Frat JP,
    2. Thille AW,
    3. Mercat A,
    4. Girault C,
    5. Ragot S,
    6. Perbet S,
    7. et al
    ; FLORALI Study Group; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185–2196.
    OpenUrlCrossRefPubMed
  3. 3.
    1. Stéphan F,
    2. Barrucand B,
    3. Petit P,
    4. Rézaiguia-Delclaux S,
    5. Médard A,
    6. Delannoy B,
    7. et al
    ; BiPOP Study Group. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA 2015;313(23):2331–2339.
    OpenUrlCrossRefPubMed
  4. 4.
    1. Messika J,
    2. Ben Ahmed K,
    3. Gaudry S,
    4. Miguel-Montanes R,
    5. Rafat C,
    6. Sztrymf B,
    7. et al
    . Use of high-flow nasal cannula oxygen therapy in subjects with ARDS: a 1-year observational study. Respir Care 2015;60(2):162–169.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Hernández G,
    2. Vaquero C,
    3. González P,
    4. Subira C,
    5. Frutos-Vivar F,
    6. Rialp G,
    7. et al
    . Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA 2016;315(13):1354–1361.
    OpenUrl
  6. 6.↵
    1. Dysart K,
    2. Miller TL,
    3. Wolfson MR,
    4. Shaffer TH
    . Research in high flow therapy: mechanisms of action. Respir Med 2009;103(10):1400–1405.
    OpenUrlCrossRefPubMed
  7. 7.
    1. Ricard JD
    . High flow nasal oxygen in acute respiratory failure. Minerva Anestesiol 2012;78(7):836–841.
    OpenUrlPubMed
  8. 8.↵
    1. Spoletini G,
    2. Alotaibi M,
    3. Blasi F,
    4. Hill NS
    . Heated humidified high-flow nasal oxygen in adults: mechanisms of action and clinical implications. Chest 2015;148(1):253–261.
    OpenUrlCrossRefPubMed
  9. 9.
    1. Papazian L,
    2. Corley A,
    3. Hess D,
    4. Fraser JF,
    5. Frat JP,
    6. Guitton C,
    7. et al
    . Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med 2016;42(9):1336–1349.
    OpenUrlPubMed
  10. 10.↵
    1. Mauri T,
    2. Turrini C,
    3. Eronia N,
    4. Grasselli G,
    5. Volta CA,
    6. Bellani G,
    7. Pesenti A
    . Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2017;195(9):1207–1215.
    OpenUrl
  11. 11.↵
    1. Delorme M,
    2. Bouchard PA,
    3. Simon M,
    4. Simard S,
    5. Lellouche F
    . Effects of high-flow nasal cannula on the work of breathing in patients recovering from acute respiratory failure. Crit Care Med 2017;45(12):1981–1988.
    OpenUrl
  12. 12.↵
    1. Mauri T,
    2. Alban L,
    3. Turrini C,
    4. Cambiaghi B,
    5. Carlesso E,
    6. Taccone P,
    7. et al
    . Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med 2017;43(10):1453–1463.
    OpenUrl
  13. 13.↵
    1. Nilius G,
    2. Franke KJ,
    3. Domanski U,
    4. Rühle KH,
    5. Kirkness JP,
    6. Schneider H
    . Effects of nasal insufflation on arterial gas exchange and breathing pattern in patients with chronic obstructive pulmonary disease and hypercapnic respiratory failure. Adv Exp Med Biol 2013;755:27–34.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Fraser JF,
    2. Spooner AJ,
    3. Dunster KR,
    4. Anstey CM,
    5. Corley A
    . Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax 2016;71(8):759–761.
    OpenUrlAbstract/FREE Full Text
  15. 15.
    1. Pisani L,
    2. Vega ML
    . Use of nasal high flow in stable COPD: rationale and physiology. COPD 2017;14(3):346–350.
    OpenUrl
  16. 16.↵
    1. Bräunlich J,
    2. Köhler M,
    3. Wirtz H
    . Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis 2016;11:1077–1085.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Bräunlich J,
    2. Wirtz H
    . NHF and hypercapnia: how brief can you look? Respirology 2017;22(6):1049–1050.
    OpenUrl
  18. 18.
    1. Storgaard LH,
    2. Hockey H-U,
    3. Laursen BS,
    4. Weinreich UM
    . Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis 2018;13:1195–1205.
    OpenUrl
  19. 19.↵
    1. Bräunlich J,
    2. Mauersberger F,
    3. Wirtz H
    . Effectiveness of nasal highflow in hypercapnic COPD patients is flow and leakage dependent. BMC Pulm Med 2018;18(1):14.
    OpenUrl
  20. 20.↵
    1. Goligher EC,
    2. Slutsky AS
    . Not just oxygen? Mechanisms of benefit from high-flow nasal cannula in hypoxemic respiratory failure. Am J Respir Crit Care Med 2017;195(9):1128–1131.
    OpenUrl
  21. 21.↵
    1. Rea H,
    2. McAuley S,
    3. Jayaram L,
    4. Garrett J,
    5. Hockey H,
    6. Storey L,
    7. et al
    . The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 2010;104(4):525–533.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Corley A,
    2. Caruana LR,
    3. Barnett AG,
    4. Tronstad O,
    5. Fraser JF
    . Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth 2011;107(6):998–1004.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Parke RL,
    2. Bloch A,
    3. McGuinness SP
    . Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers. Respir Care 2015;60(10):1397–1403.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Mündel T,
    2. Feng S,
    3. Tatkov S,
    4. Schneider H
    . Mechanisms of nasal high flow on ventilation during wakefulness and sleep. J Appl Physiol (1985) 2013;114(8):1058–1065.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Möller W,
    2. Feng S,
    3. Domanski U,
    4. Franke KJ,
    5. Celik G,
    6. Bartenstein P,
    7. et al
    . Nasal high flow reduces dead space. J Appl Physiol (1985) 2017;122(1):191–197.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Möller W,
    2. Celik G,
    3. Feng S,
    4. Bartenstein P,
    5. Meyer G,
    6. Oliver E,
    7. et al
    . Nasal high flow clears anatomical dead space in upper airway models. J Appl Physiol (1985) 2015;118(12):1525–1532.
    OpenUrlCrossRefPubMed
  27. 27.
    1. Spence CJT,
    2. Buchmann NA,
    3. Jermy MC
    . Unsteady flow in the nasal cavity with high flow therapy measured by stereoscopic PIV. Exp Fluids 2012;52(3):569–579.
    OpenUrlCrossRef
  28. 28.↵
    1. Van Hove SC,
    2. Storey J,
    3. Adams C,
    4. Dey K,
    5. Geoghegan PH,
    6. Kabaliuk N,
    7. et al
    . An experimental and numerical investigation of co2 distribution in the upper airways during nasal high flow therapy. Ann Biomed Eng 2016;44(10):3007–3019.
    OpenUrl
  29. 29.↵
    1. Vargas F,
    2. Saint-Leger M,
    3. Boyer A,
    4. Bui NH,
    5. Hilbert G
    . Physiologic effects of high-flow nasal cannula oxygen in critical care subjects. Respir Care 2015;60(10):1369–1376.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Biselli PJ,
    2. Kirkness JP,
    3. Grote L,
    4. Fricke K,
    5. Schwartz AR,
    6. Smith P,
    7. Schneider H
    . Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study. J Appl Physiol (1985) 2017;122(1):82–88.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Pisani L,
    2. Fasano L,
    3. Corcione N,
    4. Comellini V,
    5. Musti MA,
    6. Brandao M,
    7. et al
    . Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax 2017;72(4):373–375.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Brower RG,
    2. Matthay MA,
    3. Morris A,
    4. Schoenfeld D,
    5. Thompson BT,
    6. Wheeler A
    Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301–1308.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Loveridge B,
    2. West P,
    3. Anthonisen NR,
    4. Kryger MH
    . Single-position calibration of the respiratory inductance plethysmograph. J Appl Physiol Respir Environ Exerc Physiol 1983;55(3):1031–1034.
    OpenUrlPubMedWeb of Science
  34. 34.↵
    1. Baydur A,
    2. Behrakis PK,
    3. Zin WA,
    4. Jaeger M,
    5. Milic-Emili J
    . A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis 1982;126(5):788–791.
    OpenUrlPubMedWeb of Science
  35. 35.↵
    1. Akoumianaki E,
    2. Maggiore SM,
    3. Valenza F,
    4. Bellani G,
    5. Jubran A,
    6. Loring SH,
    7. et al
    ; PLUG Working Group (Acute Respiratory Failure Section of the European Society of Intensive Care Medicine). The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med 2014;189(5):520–531.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Mayaud L,
    2. Lejaille M,
    3. Prigent H,
    4. Louis B,
    5. Fauroux B,
    6. Lofaso F
    . An open-source software for automatic calculation of respiratory parameters based on esophageal pressure. Respir Physiol Neurobiol 2014;192:1–6.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Zavorsky GS,
    2. Cao J,
    3. Mayo NE,
    4. Gabbay R,
    5. Murias JM
    . Arterial versus capillary blood gases: a meta-analysis. Respir Physiol Neurobiol 2007;155(3):268–279.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Radford EP Jr.,
    2. Ferris BG Jr.,
    3. Kriete BC
    . Clinical use of a nomogram to estimate proper ventilation during artificial respiration. N Engl J Med 1954;251(22):877–884.
    OpenUrlPubMed
  39. 39.↵
    1. Nunn JF,
    2. Campbell EJ,
    3. Peckett BW
    . Anatomical subdivisions of the volume of respiratory dead space and effect of position of the jaw. J Appl Physiol 1959;14(2):174–176.
    OpenUrlPubMedWeb of Science
  40. 40.↵
    1. Onodera Y,
    2. Akimoto R,
    3. Suzuki H,
    4. Okada M,
    5. Nakane M,
    6. Kawamae K
    . A high-flow nasal cannula system with relatively low flow effectively washes out CO2 from the anatomical dead space in a sophisticated respiratory model made by a 3D printer. Intensive Care Med Exp 2018;6(1):7.
    OpenUrl
  41. 41.↵
    1. Adams CF,
    2. Geoghegan PH,
    3. Spence CJ,
    4. Jermy MC
    . Modelling nasal high flow therapy effects on upper airway resistance and resistive work of breathing. Respir Physiol Neurobiol 2018;254:23–29.
    OpenUrl
  42. 42.↵
    1. Jounieaux V,
    2. Aubert G,
    3. Dury M,
    4. Delguste P,
    5. Rodenstein DO
    . Effects of nasal positive-pressure hyperventilation on the glottis in normal awake subjects. J Appl Physiol (1985) 1995;79(1):176–185.
    OpenUrlPubMedWeb of Science
  43. 43.↵
    1. Mancebo J,
    2. Isabey D,
    3. Lorino H,
    4. Lofaso F,
    5. Lemaire F,
    6. Brochard L
    . Comparative effects of pressure support ventilation and intermittent positive pressure breathing (IPPB) in non-intubated healthy subjects. Eur Respir J 1995;8(11):1901–1909.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. Fowler WS
    . Lung function studies; the respiratory dead space. Am J Physiol 1948;154(3):405–416.
    OpenUrlWeb of Science
  45. 45.↵
    1. Fletcher R,
    2. Jonson B,
    3. Cumming G,
    4. Brew J
    . The concept of deadspace with special reference to the single breath test for carbon dioxide. Br J Anaesth 1981;53(1):77–88.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    1. Biselli P,
    2. Fricke K,
    3. Grote L,
    4. Braun AT,
    5. Kirkness J,
    6. Smith P,
    7. et al
    . Reductions in dead space ventilation with nasal high flow depend on physiological dead space volume: metabolic hood measurements during sleep in patients with COPD and controls. Eur Respir J 2018;51(5). pii: 1702251.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Plotnikow GA,
    2. Thille AW,
    3. Vasquez DN,
    4. Pratto RA,
    5. Quiroga CM,
    6. Andrich ME,
    7. et al
    . Effects of high-flow nasal cannula on end-expiratory lung impedance in semi-seated healthy subjects. Respir Care 2018;63(8):1016–1023.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Bräunlich J,
    2. Battilana M,
    3. Corley A,
    4. Coudroy R,
    5. Delorme M,
    6. Franklin D,
    7. et al
    1. Ricard J-D,
    2. et al
    . Nasal high-flow therapy in specific conditions and diseases. In: Bräunlich J, Battilana M, Corley A, Coudroy R, Delorme M, Franklin D, et al. Basics and modern practice of nasal high-flow therapy. 1st edition. Bremen: UNI-MED Science; 2019:75–86.
  49. 49.↵
    1. Roca O,
    2. Riera J,
    3. Torres F,
    4. Masclans JR
    . High-flow oxygen therapy in acute respiratory failure. Respir Care 2010;55(4):408–413.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Riera J,
    2. Pérez P,
    3. Cortés J,
    4. Roca O,
    5. Masclans JR,
    6. Rello J
    . Effect of high-flow nasal cannula and body position on end-expiratory lung volume: a cohort study using electrical impedance tomography. Respir Care 2013;58(4):589–596.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    1. Okuda M,
    2. Tanaka N,
    3. Naito K,
    4. Kumada T,
    5. Fukuda K,
    6. Kato Y,
    7. et al
    . Evaluation by various methods of the physiological mechanism of a high-flow nasal cannula (HFNC) in healthy volunteers. BMJ Open Respir Res 2017;4(1):e000200.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    1. Bräunlich J,
    2. Beyer D,
    3. Mai D,
    4. Hammerschmidt S,
    5. Seyfarth HJ,
    6. Wirtz H
    . Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration 2013;85(4):319–325.
    OpenUrlCrossRefPubMedWeb of Science
  53. 53.↵
    1. Parke RL,
    2. McGuinness SP
    . Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care 2013;58(10):1621–1624.
    OpenUrlAbstract/FREE Full Text
  54. 54.↵
    1. Tobin MJ,
    2. Jenouri G,
    3. Lind B,
    4. Watson H,
    5. Schneider A,
    6. Sackner MA
    . Validation of respiratory inductive plethysmography in patients with pulmonary disease. Chest 1983;83(4):615–620.
    OpenUrlCrossRefPubMedWeb of Science
  55. 55.↵
    1. Gonzalez H,
    2. Haller B,
    3. Watson HL,
    4. Sackner MA
    . Accuracy of respiratory inductive plethysmograph over wide range of rib cage and abdominal compartmental contributions to tidal volume in normal subjects and in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1984;130(2):171–174.
    OpenUrlPubMedWeb of Science
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords